RecruitingNCT04751760

Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

Feasibility Study of a New Immunoglobulin E (IgE) Assay Method in Urine and Blood

Sponsor

University Hospital, Toulouse

Enrollment

1,376 participants

Start Date

Apr 20, 2021

Study Type

OBSERVATIONAL

Conditions

Allergy and Immunology

Summary

The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.

Eligibility

Min Age: 6 MonthsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called collection of blood and urine for people with allergy and immunology. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 6 Months to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.